Cargando…

T Cell Repertoire Abnormality in Immunodeficiency Patients with DNA Repair and Methylation Defects

Both DNA damage response and methylation play a crucial role in antigen receptor recombination by creating a diverse repertoire in developing lymphocytes, but how their defects relate to T cell repertoire and phenotypic heterogeneity of immunodeficiency remains obscure. We studied the TCR repertoire...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Mingyan, Su, Zheng, Abolhassani, Hassan, Zhang, Wei, Jiang, Chongyi, Cheng, Bochen, Luo, Lihua, Wu, Jinghua, Wang, Shiyu, Lin, Liya, Wang, Xie, Wang, Longlong, Aghamohammadi, Asghar, Li, Tao, Zhang, Xiuqing, Hammarström, Lennart, Liu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821531/
https://www.ncbi.nlm.nih.gov/pubmed/34825286
http://dx.doi.org/10.1007/s10875-021-01178-1
Descripción
Sumario:Both DNA damage response and methylation play a crucial role in antigen receptor recombination by creating a diverse repertoire in developing lymphocytes, but how their defects relate to T cell repertoire and phenotypic heterogeneity of immunodeficiency remains obscure. We studied the TCR repertoire in patients with the mutation in different genes (ATM, DNMT3B, ZBTB24, RAG1, DCLRE1C, and JAK3) and uncovered distinct characteristics of repertoire diversity. We propose that early aberrancies in thymus T cell development predispose to the heterogeneous phenotypes of the immunodeficiency spectrum. Shorter CDR3 lengths in ATM-deficient patients, resulting from a decreased number of nucleotide insertions during VDJ recombination in the pre-selected TCR repertoire, as well as the increment of CDR3 tyrosine residues, lead to the enrichment of pathology-associated TCRs, which may contribute to the phenotypes of ATM deficiency. Furthermore, patients with DNMT3B and ZBTB24 mutations who exhibit discrepant phenotypes present longer CDR3 lengths and reduced number of known pathology-associated TCRs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-021-01178-1.